Regulation of gender-dependent CYP2A expression in pigs: Involvement of androgens and CAR

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 5, 2006, Pages 480-487

  Gillberg, Mette ^a,b   Skaanild, Mette T ^a   Friis, Christian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Department of Veterinary Pathobiology ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; 5ALPHA ANDROSTEN 3ALPHA OL; 6 (4 CHLOROPHENYL)IMIDAZO[2,1 B][1,3]THIAZOLE 5 CARBALDEHYDE O (3,4 DICHLOROBENZYL) OXIME; ANDROGEN; ANDROSTANE DERIVATIVE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2A; ESTRONE; LIGAND; MESSENGER RNA; OXIME; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; LIVER; LIVER CELL; MINIPIG; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELLS, CULTURED; COUMARINS; CYTOCHROME P-450 CYP3A; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; LIVER; MALE; ORCHIECTOMY; OXIMES; PHENOBARBITAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RNA, MESSENGER; SEX FACTORS; STEROID HYDROXYLASES; SWINE; SWINE, MINIATURE; THIAZOLES; TRANSCRIPTION FACTORS;

ANIMALIA; MURINAE; SUIDAE;

EID: 33646256118     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_261.x     Document Type: Article

References (29)

1. Anzenbacher, P., P. Soucek, E. Anzenbacherova, I. Gut, K. Hrubý, Z. Svoboda & J. Kvêtina: Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Drug Metab. Disp. 1998, 26, 56-59.
2. Bogaards, J. J. P., M. Bertrand, P. Jackson, M. J. Oudshoorn, R. J. Weaver, P. J. van Bladeren & B. Walther: Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000, 30, 1131-1152.
3. Cai, Y., T. Konishi, G. Han, K. H. Campwala, S. W. French & Y. Y. Wan: The role of hepatocyte RXRa in xenobiotic-sensing nuclear receptor-mediated pathways. Eur. J. Pharmaceut. Sci. 2002, 15, 89-96.
4. Donato, M. T., P. Viitala, C. Rodriguez-Antona, A. Lindfors, J. V. Castell, H. Raunio, M. J. Gómez-Lechón, & O. Pelkonen: CYP2A5/CYP2A6 expression in mouse and human hepatocytes treated with various in vivo inducers. Drug Metab. Disp. 2000, 28, 1321-1326.
5. Forman, B. M., I. Tzameli, H.-S. Choi, J. Chen, D. Simha, W. Seol, R. M. Evans & D. D. Moore: Androstane metabolites bind to and deactivate the nuclear receptor CAR. Nature 1998, 395, 612-615.
6. Gandhi, M., F. Aweeka, R. M. Greenblatt & T. F. Blaschke: Sex differences in pharmacokinetics and pharmacodynamics. Ann. Rev. Pharmacol. Toxicol. 2004, 44, 499-523.
7. Hakkola, J., M. Pasanen, J. Hukkanen, O. Pelkonen, J. Mäenpää, R. J. Edwards, A. R. Boobis & H. Raunio: Expression of xenobiotic-metabolizing cytochrome P450 forms in human placenta. Biochem. Pharmacol. 1996, 51, 403-411.
8. Kawamoto, T., S. Kakizaki, K. Yoshinari & M. Negishi: Estrogen activation of the nuclear orphan receptor CAR (Constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol. Endocrinol. 2000, 14, 1897-1905.
9. Madan, A., R. A. Graham, K. M. Carroll, D. R. Mudra, L. A. Burton, L. A. Krueger, A. D. Downey, M. Czerwinski, J. Forster, M. D. Ribadeneira, L. S. Gan, E. L. LeCluyse, K. Zech, P. Robertson, P. Koch, L. Antonian, G. Wagner, L. Yu & A. Parkinson: Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab. Disp. 2003, 31, 421-431.
10. Maglich, J. M., D. J. Parks, L. B. Moore, J. L. Collins, B. Goodwin, A. N. Billin, C. A. Stoltz, S. A. Kliewer, M. H. Lambert, T. M. Willson & J. T. Moore: Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 2003, 278, 17277-17283.
11. Meunier, V., M. Bourrié, B. Julian, E. Marti, F. Guillou, Y. Berger & G. Fabre: Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up. Xenobiotica 2000, 30, 589-607.
12. Monschouwer, M., R. F. Witkamp, S. M. Nijmeijer, J. G. van Amsterdam & A. S. J. van Miert: Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol. Appl. Pharmacol. 1996, 137, 237-244.
13. Moore, L. B., D. J. Parks, S. A. Jones, R. K. Bledsoe, T. G. Consler, J. B. Stimmel, B. Goodwin, C. Liddle, S. G. Blanchard, T. M. Willson, J. L. Collins & S. A. Kliewer: Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 2000, 275, 15122-15127.
14. Mugford, C. A. & G. L. Kedderis: Sex-dependent metabolism of xenobiotics. Drug Metab. Rev. 1998, 30, 441-498.
15. Olsen, A. K., K. T. Hansen & C. Friis: Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17-ethynylestradiol. Chem.-Biol. Interac. 1997, 107, 93-108.
16. Omura, T. & R. Sato: The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 1964, 239, 2379-2385.
17. Pelkonen, O., A. Rautio, H. Raunio & M. Pasanen: CYP2A6: A human coumarin 7-hydroxylase. Toxicology 2000, 144, 139-147.
18. Peterson, G. L.: A simplification of the protein assay method of Lowry et al. which is more generally applicable. Analyt. Biochem. 1977, 83, 346-356.
19. Posti, K., S. Leinonen, S. Tetri, S. Kottari, P. Viitala, O. Pelkonen & H. Raunio: Modulation of murine phenobarbital-inducible CYP2A5, CYP2B10 and CYP1A enzymes by inhibitors of protein kinases and phosphatases. Europ. J. Biochem. 1999, 264, 19-26.
20. Raunio, H., A. Rautio & O. Pelkonen: The CYP2A subfamiliy: function, expression and genetic polymorphism. IARC Sci. Pub. 1999, 148, 197-207.
21. Salonpää, P., S. Kottari, O. Pelkonen & H. Raunio: Regulation of CYP2A5 induction by porphyrinogenic agents in mouse primary hepatocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 355, 8-13.
22. Salonpää, P., O. Pelkonen, A. Kojo, M. Pasanen, M. Negishi & H. Raunio: Cytochrome P4502A5 expression and inducibility by phenobarbital is modulated by cAMP in mouse primary hepatocytes. Biochem. Biophys. Res. Commun. 1994, 205, 631-637.
23. Skaanild, M. T. & C. Friis: Characterization of the P450 system in Göttingen minipigs. Pharmacology & Toxicology 1997, 80, 28-33.
24. Skaanild, M. T. & C. Friis: Cytochrome P450 sex differences in minipigs and conventional pigs. Pharmacology & Toxicology 1999, 85, 174-180.
25. Skaanild, M. T. & C. Friis: Expression Changes of CYP2A and CYP3A in Microsomes from Pig Liver and Cultured Hepatocytes. Pharmacology & Toxicology 2000, 87, 174-178.
26. Skaanild, M. T.& C. Friis: Porcine CYP2A Polymorphisms and Activity. Basic and Clinical Pharmacology & Toxicology 2005, 97, 115-121.
27. Smith, D. A.: Species differences in metabolism and pharmacokinetics: Are we close to an understanding? Drug Metab. Rev. 1991, 23, 355-373.
28. Tanaka, E.: Gender-related differences in pharmacokinetics and their clinical significance. J. Clin. Pharm. Therap. 1999, 24, 339-346.
29. Wolbold, R., K. Klein, O. Burk, A. K. Nüssler, P. Neuhaus, M. Eichelbaum, M. Schwab & U. M. Zanger: Sex is a Major Determinant of CYP3A4 Expression in Human Liver. Hepatology 2003, 38, 978-988.